Genmab AS (GMAB)
20.46
-0.30
(-1.45%)
USD |
NASDAQ |
Dec 24, 13:00
20.46
0.00 (0.00%)
After-Hours: 13:44
Genmab Profit Margin (Quarterly): 22.85% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Novo Nordisk AS | 38.28% |
| Ascendis Pharma AS | -171.5% |
| Galecto Inc | -- |
| Evaxion Biotech AS | -64.14% |
| IO Biotech Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 14.86% |
| Return on Assets | 12.66% |
| Return on Invested Capital | 14.86% |
| Gross Profit Margin (Quarterly) | 95.07% |
| Operating Margin (Quarterly) | 38.25% |
| Return on Net Operating Assets | 35.82% |